Cosmo Bio Co., Ltd. (3386) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cosmo Bio Co., Ltd. (3386:JPX), powered by AI.

Current Price
¥1,264
P/E Ratio
28.1
Market Cap
7.4B
Sector
Healthcare
What is the Cosmo Bio Co., Ltd. stock price forecast?

Cosmo Bio Co., Ltd. is currently trading at ¥1,264. View real-time AI analysis on Alpha Lenz.

What is Cosmo Bio Co., Ltd. insider trading activity?

View the latest insider trading data for Cosmo Bio Co., Ltd. on Alpha Lenz.

What is Cosmo Bio Co., Ltd.'s P/E ratio?

Cosmo Bio Co., Ltd.'s P/E ratio is 28.1.

Cosmo Bio Co., Ltd.

JPX · 3386
¥1,264+9(+0.72%)Market closedJPX regular session 09:00–15:00 JST
Ask about Cosmo Bio Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Cosmo Bio Co., Ltd. trades at a P/E of 28.1 (premium valuation) with modest ROE of 3.0%.

Ask for details

Company Overview

Cosmo Bio Co., Ltd. is a Japanese company specializing in the distribution and sale of life science products and services. It plays a crucial role in the biotechnology sector by providing essential research materials and laboratory supplies. The company's primary function is to support scientific research and development, particularly in the fields of medical and biological research. Cosmo Bio Co., Ltd. offers a diverse range of products, including antibodies, enzymes, assay kits, and cell culture media, catering to the needs of researchers and institutions engaged in various scientific endeavors. Significantly, Cosmo Bio is instrumental in facilitating advancements in healthcare and biotechnology through its extensive product catalog. It serves multiple industries, including pharmaceuticals, universities, environmental research, and diagnostic laboratories. By enabling access to high-quality, innovative research tools, Cosmo Bio Co., Ltd. supports groundbreaking work in areas such as disease understanding, drug development, and genetic research. Situated in a competitive market, the company remains a pivotal figure in the Japanese life sciences supply chain, contributing to the advancement of scientific knowledge and the improvement of health outcomes globally.

SectorHealthcare
IndustryDiagnostics & Research
Employees174

Company Statistics

FY 2024

Profile

¥7,351,249,568Market Cap
¥10,037,000,000Revenue
0.00Shares Out
174Employees

Margins

33.17%Gross
5.00%EBITDA
3.18%Operating
3.68%Pre-Tax
2.68%Net

Valuation

28.06P/E
0.82P/B
0.73EV/Sales
11.09EV/EBITDA
-210.04P/FCF

Growth (CAGR)

2.83%Rev 3Yr
5.75%Rev 5Yr
-32.75%Op Inc 3Yr
-4.66%Op Inc 5Yr
-29.51%Net Inc 3Yr
1.80%Net Inc 5Yr

Returns

2.38%ROA
3.01%ROE
3.27%ROIC

Financial Health

¥2,393,000,000Cash & Cash Equivalents
¥-223,000,000Net Debt
22.72%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Cosmo Bio Co., Ltd. (ticker: 3386) is a company listed on JPX in the Healthcare sector (Diagnostics & Research). It has approximately 174 employees. Market cap is $7.4B.

The current price is 1,264 with a P/E ratio of 28.06x and P/B of 0.82x.

ROE is 3.01% and operating margin is 3.18%. Annual revenue is $10.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Cosmo Bio Co., Ltd. (Healthcare) Stock Forecast & Analysis ¥1,264 | Alpha Lenz